25 10, 2022 Andromachi Kotsafti et al., Tumor immune microenvironment in therapy-naive esophageal adenocarcinoma could predict the nodal status adlitterio663392022-10-25T11:39:16+02:00 Read More
13 10, 2022 Clotilde Sparano et al., Classic and follicular variant of papillary thyroid microcarcinoma: two different phenotypes beyond tumour size adlitterio663392022-10-20T11:38:05+02:00 Read More
1 08, 2022 Pina Ziranu et al., CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors adlitterio663392022-10-20T11:57:14+02:00 Read More
23 07, 2022 Chiara Nicolazzo et al., A Fast and Furious Liquid Biopsy Assay to Monitor Targeted Therapy Resistance adlitterio663392022-10-14T11:22:50+02:00 Read More
5 07, 2022 Liborio Torregrossa et al., The Italian Consensus for the Classification and Reporting of Thyroid Cytology: Cytohistologic and molecular correlations on 37,371 nodules from a single institution adlitterio663392022-10-14T11:25:30+02:00 Read More
25 06, 2022 Thais Maloberti et al., BRAF and MLH1 Analysis Algorithm for the Evaluation of Lynch Syndrome Risk in Colorectal Carcinoma Patients: Evidence-Based Data from the Analysis of 100 Consecutive Cases adlitterio663392022-10-14T11:35:41+02:00 Read More
9 06, 2022 Jana Fassunke et al., Biomarker testing in lung cancer patients- upscaling the fast track analysis adlitterio663392022-10-14T11:08:32+02:00 Read More
1 06, 2022 Gian Franco Zannoni et al., Biomarker characterization in endometrial cancer in Italy: first survey data analysis adlitterio663392022-10-20T12:08:07+02:00 Read More
1 06, 2022 Gian Franco Zannoni et al., Biomarker characterization in endometrial cancer in Italy: first survey data analysis adlitterio663392022-10-14T11:29:19+02:00 Read More
6 05, 2022 Cristina Morelli et al., Concordance of Blood-Based and Normal Tissue-Based Dihydropyrimidine Dehydrogenase (DPYD) Genotyping adlitterio663392022-10-14T11:46:30+02:00 Read More
